Eli Lilly and Bayer Criticize Germany's Spending on New Medicines

Pharmaceutical giants Eli Lilly and Bayer have voiced strong criticism against Germany's expenditure on new medicines, indicating support for the US pushback on drug price legislation.

23 Jun, 17:29 — 23 Jun, 17:29

Post Share

Sources

Showing 1 of 1 sources

FTVery High63d ago

Eli Lilly and Bayer hit out at Germany’s spending on new medicines

Pharma groups indicate support for US pushback on legislation to lower drug prices

Read full article →

PERSPECTA

PERSPECTA

Eli Lilly and Bayer Criticize Germany's Spending on New Medicines

Sources

Eli Lilly and Bayer hit out at Germany’s spending on new medicines

Related Stories

SpaceX Announces $100 Billion 'Spaceport' In US' Louisiana

"All Accurate": Musk Confirms Massive New Starship Rocket Base In Louisiana

Aprea Therapeutics and Capricor Therapeutics Stocks Surge

Goldman Sachs Downgrades Daqo New Energy to Sell Due to Valuation

PERSPECTA